Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New QP requirements 'in sync with real world', but EU drug industry concerns persist

This article was originally published in SRA

Executive Summary

Pharmaceutical companies have largely welcomed the European Commission's revised draft guideline on qualified person (QP) requirements as the update aims to bring the document in line with the current globalized nature of the drug industry1,2. They are, however, worried about the practical implementation of some of the provisions in the proposed guideline, saying these could lead to unnecessary challenges "while feasible alternatives are at hand".

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS117654

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel